Opinion
Video
Author(s):
A panel of experts on bladder cancer introduce themselves and give an overview of the neoadjuvant therapy landscape for patients with muscle-invasive bladder cancer.
Temple University Hospital and Fox Chase Researchers Investigate Survival Outcomes Following Adjuvant Treatment in Clinical T2N0 Rectal Cancer Patients
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Braun Spotlights Novel Treatment Developments in RCC
Kitko and Patel Emphasize the Importance of GVHD Research and Awareness
Braun Highlights Advances in RCC Treatment Paradigm, Looks Towards Future
Advancements With Combination Therapies in RCC Usher in New Questions
Talquetamab Produces Responses in R/R Myeloma After Prior T-Cell–Directed Therapies
Lurbinectedin Plus Irinotecan Is Safe, Prolongs Responses in High-Risk, Pretreated SCLC
Axi-Cel Shows Safety, Clinical Activity in R/R Primary and Secondary CNS Lymphomas
Amphiphile Lymph Node–Targeted Vaccine Is Safe and Bolsters T-Cell Responses in MRD+ PDAC and CRC